about
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidat...
Read More
18.49
-0.57
(-2.99%)
84,835
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Surrozen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..